EV/EBITDA
-25.83
-1.38-5.64%
Thu, 28 Nov 2024 00:46:21 GMT
Summary:
Taysha Gene Therapies EV/EBITDA is currently -25.83, with a fall of -1.38 (-5.64%) during the most recent trading day. Over the past year, it has dropped by -24.71 (-2206.25%). TSHA EV/EBITDA is now -28600.00% below its all-time high of -0.09.TSHA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -5.6% |
1 m1 month | -64.3% |
3 m3 months | -758.1% |
6 m6 months | -456.7% |
ytdytd | -980.8% |
1 y1 year | -2206.3% |
5 y5 years | - |
TSHA EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -8.09 | -219.3% | -25.83 | at low |
3 m | 3 months | -2.64 | -878.4% | -25.83 | at low |
6 m | 6 months | -2.54 | -916.9% | -25.83 | at low |
1 y | 1 year | -0.85 | -2938.8% | -25.83 | at low |
3 y | 3 years | -0.09 | <-9999.0% | -25.83 | at low |
5 y | 5 years | -0.09 | <-9999.0% | -31.19 | +17.2% |
alltime | all time | -0.09 | <-9999.0% | -31.19 | +17.2% |
Taysha Gene Therapies EV/EBITDA History
Date | Value |
---|---|
2024 | -25.83(+980.8%) |
2023 | -2.39(+236.6%) |
Date | Value |
---|---|
2022 | -0.71(-66.2%) |
2021 | -2.10(-83.2%) |
2020 | -12.52 |
FAQ
- What is Taysha Gene Therapies EV/EBITDA?
- What is the all time high EV/EBITDA for Taysha Gene Therapies?
- What is TSHA EV/EBITDA year-to-date change?
- What is Taysha Gene Therapies EV/EBITDA year-on-year change?
What is Taysha Gene Therapies EV/EBITDA?
The current EV/EBITDA of TSHA is -25.83
What is the all time high EV/EBITDA for Taysha Gene Therapies?
Taysha Gene Therapies all-time high EV/EBITDA is -0.09
What is TSHA EV/EBITDA year-to-date change?
Taysha Gene Therapies EV/EBITDA has changed by -23.44 (-980.75%) since the beginning of the year
What is Taysha Gene Therapies EV/EBITDA year-on-year change?
Over the past year, TSHA EV/EBITDA has changed by -24.71 (-2206.25%)